| |
Drug Targets
Finding appropriate drug targets for infectious diseases requires a great deal of research, focusing on molecular approaches to identify important cellular differences between parasites and their human hosts.
Many of SBRI’s scientists are focused on this type of research. For example, scientists at SBRI,
led by Ken Stuart, Ph.D.,
made the breakthrough discovery of RNA editing, which provides a potential basis for drug treatments for
three major parasitic diseases. Another group of researchers,
headed by Peter Myler, Ph.D.,
has completed sequencing the genome of the
parasite that causes
leishmania.
This information will provide the basis for new or improved drug targets to combat that disease.
|
|
